ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Internal Medicine

Top Internal Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LUTHER EMERSON M.D.

Internal Medicine

280

$18.6K

65
62 are 65+

49%
patients receiving schedule two controlled substances

Avg: 10%

26%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

MICHAEL CORRIGAN MD

Internal Medicine

8,260

$635K

330
186 are 65+

22%
patients receiving schedule two controlled substances

Avg: 10%

18%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $63

CAROLYN TAYLOR-OLSON MD

Internal Medicine

1,825

$82.6K

92
84 are 65+

23%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $63

AUDREY VONLEPEL M.D.

Internal Medicine

6,387

$342K

252
189 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $63

JEFFREY STALL M.D.

Internal Medicine

5,219

$466K

205
127 are 65+

20%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $63

TEIG MARCO M.D.

Internal Medicine

13,856

$803K

452
382 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

BARBARA MASLEY M.D.

Internal Medicine

4,787

$337K

315
184 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $63

LOUIS MEYERS M.D.

Internal Medicine

5,379

$328K

243
159 are 65+

19%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $63

PAMELA PEDERSEN M.D,

Internal Medicine

6,702

$337K

259
174 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

16%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $63

NICOLE BELANGER MD

Internal Medicine

2,832

$179K

198
158 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

17%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

MELISSA BRANDES M.D.

Internal Medicine

3,492

$320K

184
136 are 65+

21%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $63

PETER GUNTHER M.D.

Internal Medicine

4,284

$469K

284
217 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $63

MARK PITCHER M.D.

Internal Medicine

9,192

$584K

450
381 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $63

ANTHONY WILLIAMS MD, FACP

Internal Medicine

6,128

$316K

293
188 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $63

MICHAEL SCOVNER MD

Internal Medicine

6,966

$444K

305
211 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $63

ERIC POFCHER M.D.

Internal Medicine

1,482

$122K

206
130 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $63

KATHERINE DEVINE MD

Internal Medicine

3,161

$159K

201
149 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $63

MARK PASANEN MD

Internal Medicine

5,204

$514K

328
174 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $63

JAMES CURRIE MD

Internal Medicine

3,914

$254K

244
155 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

AYDIN LATHARI M.D.

Internal Medicine

2,516

$146K

133
92 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

JOHN LEPPMAN MD

Internal Medicine

5,717

$268K

368
175 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $63

DEBORAH SCOTT MD

Internal Medicine

3,232

$191K

185
130 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $63

PRISCILLA CARR MD

Internal Medicine

5,279

$304K

215
181 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $63

MARK JEWETT M.D.

Internal Medicine

3,926

$271K

164
121 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $63

PETER STICKNEY MD

Internal Medicine

11,924

$864K

428
368 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$73
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank